Alzheimer’s disease (AD), a neurodegenerative disorder with progressive cognitive decline, remains clinically challenging with limited understanding of etiology and interventions. Clinical studies have reported vascular defects prior to other pathological manifestations of AD, leading to the “Vascular Hypothesis” for the disorder. However, in vivo assessments of cerebral vasculature in AD rodent models have been constrained by limited spatiotemporal resolution or field of view of conventional imaging. We herein employed two in vivo imaging technologies, Dual-Wavelength Imaging and Optical Coherence Doppler Tomography, to evaluate cerebrovascular reactivity (CVR) to vasoconstrictive cocaine and vasodilatory hypercapnia challenges and to detect resting 3D cerebral blood flow (CBF) in living transgenic AD mice at capillary resolution. Results showed that CVR to cocaine and hypercapnia was significantly attenuated in 7–10 months old AD mice vs controls, indicating reduced vascular flexibility and reactivity. Additionally, in the AD mice, arterial CBF velocities were slower and the microvascular density in cortex was decreased compared to controls. These results reveal significant vascular impairments including reduced CVR and resting CBF in early-staged AD mice. Hence, this cutting-edge in vivo optical imaging offers an innovative venue for detecting early neurovascular dysfunction in AD brain with translational potential.
BallardCGauthierSCorbettA, et al.
Alzheimer's disease. Lancet2011;
377: 1019–1031.
2.
HardyJAHigginsGA.Alzheimer's disease: the amyloid cascade hypothesis. Science1992;
256: 184–185.
3.
DavisDGSchmittFAWeksteinDR, et al.
Alzheimer neuropathologic alterations in aged cognitively normal subjects. J Neuropathol Exp Neurol1999;
58: 376–388.
4.
de la TorreJCMussivandT.Can disturbed brain microcirculation cause Alzheimer's disease?Neurol Res1993;
15: 146–153.
5.
DicksteinDLWalshJBrautigamH, et al.
Role of vascular risk factors and vascular dysfunction in Alzheimer's disease. Mt Sinai J Med2010;
77: 82–102.
6.
Rius-PérezSTormosAMPérezS, et al.
Vascular pathology: cause or effect in Alzheimer disease?Neurología (English Edition)2018;
33: 112–120.
7.
SchefferSHermkensDMAWeerdL, et al.
Vascular hypothesis of Alzheimer disease. Arterioscler Thromb Vasc Biol2021;
41: 1265–1283.
8.
Iturria-MedinaYSoteroRCToussaintPJ, et al.
Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis. Nat Commun2016;
7: 11934.
9.
Iturria-MedinaYCarbonellFMSoteroRC, Alzheimer's Disease Neuroimaging Initiativeet al.
Multifactorial causal model of brain (dis)organization and therapeutic intervention: application to Alzheimer's disease. Neuroimage2017;
152: 60–77.
10.
JellingerKA.Alzheimer disease and cerebrovascular pathology: an update. J Neural Transm (Vienna)2002;
109: 813–836.
11.
WoltersFJZonneveldHIHofmanA, et al.
Cerebral perfusion and the risk of dementia: a population-based study. Circulation2017;
136: 719–728.
12.
WardlawJMMakinSJValdés HernándezMC, et al.
Blood-brain barrier failure as a core mechanism in cerebral small vessel disease and dementia: evidence from a cohort study. Alzheimer's Dementia2017;
13: 634–643.
13.
GreenbergSMBacskaiBJHernandez-GuillamonM, et al.
Cerebral amyloid angiopathy and Alzheimer disease – one peptide, two pathways. Nat Rev Neurol2020;
16: 30–42.
14.
FisherRAMinersJSLoveS.Pathological changes within the cerebral vasculature in Alzheimer's disease: new perspectives. Brain Pathol2022;
32: e13061.
15.
Baglietto-VargasDFornerSCaiL, et al.
Generation of a humanized Aβ expressing mouse demonstrating aspects of Alzheimer's disease-like pathology. Nat Commun2021;
12: 2421.
16.
KshirsagarSAlvirRVHindleA, et al.
Early cellular, molecular, morphological and behavioral changes in the humanized amyloid-beta-knock-in mouse model of late-onset Alzheimer's disease. Cells2022;
11: 20220219.
17.
LiuPDe VisJBLuH.Cerebrovascular reactivity (CVR) MRI with CO2 challenge: a technical review. NeuroImage2019;
187: 104–115.
18.
ChenJJ.Cerebrovascular-reactivity mapping using MRI: considerations for Alzheimer’s disease. Front Aging Neurosci2018;
10: 170. Mini Review.
19.
SleightEStringerMSMarshallI, et al.
Cerebrovascular reactivity measurement using magnetic resonance imaging: a systematic review. Front Physiol2021;
12: 643468. Systematic review.
20.
HayesGPintoJSparksSN, et al.
Vascular smooth muscle cell dysfunction in neurodegeneration. Front Neurosci2022;
16: 1010164. Review.
21.
FierstraJSobczykOBattisti-CharbonneyA, et al.
Measuring cerebrovascular reactivity: what stimulus to use?J Physiol2013;
591: 5809–5821.
22.
VicenziniERicciardiMCAltieriM, et al.
Cerebrovascular reactivity in degenerative and vascular dementia: a transcranial doppler study. Eur Neurol2007;
58: 84–89.
23.
CantinSVillienMMoreaudO, et al.
Impaired cerebral vasoreactivity to CO2 in Alzheimer's disease using BOLD fMRI. Neuroimage2011;
58: 579–587.
24.
RichiardiJMonschAUHaasT, et al.
Altered cerebrovascular reactivity velocity in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging2015;
36: 33–41.
25.
KimDHughesTMLipfordME, et al.
Relationship between cerebrovascular reactivity and cognition among people with risk of cognitive decline. Front Physiol2021;
12: 645342. Original Research.
26.
RodellAAanerudJBraendgaardH, et al.
Low residual CBF variability in Alzheimer’s disease after correction for CO2 effect. Front Neuroenergetics2012;
4: 8. Original Research.
27.
GlodzikLRandallCRusinekH, et al.
Cerebrovascular reactivity to carbon dioxide in Alzheimer's disease. J Alzheimers Dis2013;
35: 427–440.
28.
PintoJBrightMGBulteDP, et al.
Cerebrovascular reactivity mapping without gas challenges: a methodological guide. Front Physiol2020;
11: 608475. Review.
29.
OgawaSMenonRSTankDW, et al.
Functional brain mapping by blood oxygenation level-dependent contrast magnetic resonance imaging. A comparison of signal characteristics with a biophysical model. Biophys J1993;
64: 803–812.
30.
ChenJJPikeGB.Global cerebral oxidative metabolism during hypercapnia and hypocapnia in humans: implications for BOLD fMRI. J Cereb Blood Flow Metab2010;
30: 1094–1099.
31.
LeeS-PDuongTQYangG, et al.
Relative changes of cerebral arterial and venous blood volumes during increased cerebral blood flow: implications for BOLD fMRI. Magn Reson Med2001;
45: 791–800.
32.
LeeS-PSilvaACUgurbilK, et al.
Diffusion-weighted spin-echo fMRI at 9.4 T: Microvascular/tissue contribution to BOLD signal changes. Magn Reson Med1999;
42: 919–928.
33.
WilliamsDSDetreJALeighJS, et al.
Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc Natl Acad Sci U S A1992;
89: 212–216.
34.
BangenKJRestomKLiuTT, et al.
Differential age effects on cerebral blood flow and BOLD response to encoding: associations with cognition and stroke risk. Neurobiol Aging2009;
30: 1276–1287.
35.
Yao J and Wang LV. Photoacoustic microscopy. Laser Photon Rev 2013; 7: 10.1002/lpor.201200060.
36.
KleinfeldDMitraPPHelmchenF, et al.
Fluctuations and stimulus-induced changes in blood flow observed in individual capillaries in layers 2 through 4 of rat neocortex. Proc Natl Acad Sci U S A1998;
95: 15741–15746.
37.
TakanoTHanXDeaneR, et al.
Two-photon imaging of astrocytic Ca2+ signaling and the microvasculature in experimental mice models of Alzheimer's disease. Ann N Y Acad Sci2007;
1097: 40–50.
38.
ZhaoYChenZSaxerC, et al.
Phase-resolved optical coherence tomography and optical doppler tomography for imaging blood flow in human skin with fast scanning speed and high velocity sensitivity. Opt Lett2000;
25: 114–116.
39.
HuSYanPMaslovK, et al.
Intravital imaging of amyloid plaques in a transgenic mouse model using optical-resolution photoacoustic microscopy. Opt Lett2009;
34: 3899–3901.
LiuCWangL.Functional photoacoustic microscopy of hemodynamics: a review. Biomed Eng Lett2022;
12: 97–124.
42.
RapoportRMYoonSZuccarelloM.Cocaine constrictor mechanisms of the cerebral vasculature. J Cardiovasc Pharmacol2016;
67: 442–450.
43.
DuCKoretskyAPIzrailtyanI, et al.
Simultaneous detection of blood volume, oxygenation, and intracellular calcium changes during cerebral ischemia and reperfusion in vivo using diffuse reflectance and fluorescence. J Cereb Blood Flow Metab2005;
25: 1078–1092.
44.
DuCYuMVolkowND, et al.
Cocaine increases the intracellular calcium concentration in brain independently of its cerebrovascular effects. J Neurosci2006;
26: 11522–11531.
45.
RenHDuCYuanZ, et al.
Cocaine-induced cortical microischemia in the rodent brain: clinical implications. Mol Psychiatry2012;
17: 1017–1025.
46.
YouJDuCVolkowND, et al.
Optical coherence doppler tomography for quantitative cerebral blood flow imaging. Biomed Opt Express2014;
5: 3217–3230.
47.
ParkKYouJDuC, et al.
Cranial window implantation on mouse cortex to study microvascular change induced by cocaine. Quant Imaging Med Surg2015;
5: 97–107.
48.
YuanZLuoZVolkowND, et al.
Imaging separation of neuronal from vascular effects of cocaine on rat cortical brain in vivo. NeuroImage2011;
54: 1130–1139.
49.
ChenWParkKVolkowND, et al.
Cocaine-Induced abnormal cerebral hemodynamic responses to forepaw stimulation assessed by integrated multi-wavelength spectroimaging and laser speckle contrast imaging. IEEE J Select Topic Quant Electron2016;
22: 146–153.
50.
KetySSSchmidtCF.The effects of altered arterial tensions of carbon dioxide and oxygen on cerebral blood flow and cerebral oxygen consumption of normal young men. J Clin Invest1948;
27: 484–492.
51.
LiuYHuaYParkK, et al.
Cocaine’s cerebrovascular vasoconstriction is associated with astrocytic Ca2+ increase in mice. Commun Biol2022;
5: 936.
52.
2022 Alzheimer's disease facts and figures. Alzheimer's Dementia2022;
18: 700–789.
53.
GuoLZhongMBZhangL, et al.
Sex differences in Alzheimer’s disease: insights from the multiomics landscape. Biol Psychiatry2022;
91: 61–71.
LaMannaJCChavezJCPichiuleP.Structural and functional adaptation to hypoxia in the rat brain. J Exp Biol2004;
207: 3163–3169.
56.
ZhangQYouJVolkowND, et al.
Chronic cocaine disrupts neurovascular networks and cerebral function: optical imaging studies in rodents. J Biomed Opt2016;
21: 26006.
57.
NatarajanRNorthropNYamamotoB.Fluorescein isothiocyanate (FITC)-dextran extravasation as a measure of blood-brain barrier permeability. Curr Protoc Neurosci2017;
79: 9.58.1–9.58.15.
58.
LuoZYuanZPanY, et al.
Simultaneous imaging of cortical hemodynamics and blood oxygenation change during cerebral ischemia using dual-wavelength laser speckle contrast imaging. Opt Lett2009;
34: 1480–1482.
59.
YuanZLuoZCRenHG, et al.
A digital frequency ramping method for enhancing doppler flow imaging in Fourier-domain optical coherence tomography. Opt Express2009;
17: 3951–3963.
60.
FaraciFMHeistadDD.Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol Rev1998;
78: 53–97.
61.
BaloyannisSJBaloyannisIS.The vascular factor in Alzheimer's disease: a study in golgi technique and electron microscopy. J Neurol Sci2012;
322: 117–121.
62.
KalariaRNHarikSI.Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer disease. J Neurochem1989;
53: 1083–1088.
63.
MerliniMMeyerEPUlmann-SchulerA, et al.
Vascular β-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAβ mice. Acta Neuropathol2011;
122: 293–311.
64.
WinklerEANishidaYSagareAP, et al.
GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration. Nat Neurosci2015;
18: 521–530.
65.
VillaLMSalasEDarley-UsmarVM, et al.
Peroxynitrite induces both vasodilatation and impaired vascular relaxation in the isolated perfused rat heart. Proc Natl Acad Sci U S A1994;
91: 12383–12387.
66.
KelleherRJSoizaRL.Evidence of endothelial dysfunction in the development of Alzheimer's disease: is Alzheimer's a vascular disorder?Am J Cardiovasc Dis2013;
3: 197–226.
67.
GrammasPTripathyDSanchezA, et al.
Brain microvasculature and hypoxia-related proteins in Alzheimer's disease. Int J Clin Exp Pathol2011;
4: 616–627.
68.
ShimohamaSTaninoHKawakamiN, et al.
Activation of NADPH oxidase in Alzheimer's disease brains. Biochem Biophys Res Commun2000;
273: 5–9.
69.
KishidaKTPaoMHollandSM, et al.
NADPH oxidase is required for NMDA receptor-dependent activation of ERK in hippocampal area CA1. J Neurochem2005;
94: 299–306.
70.
SorceSKrauseK-H.NOX enzymes in the central nervous system: from signaling to disease. Antioxid Redox Signal2009;
11: 2481–2504.
71.
NunomuraAPerryGAlievG, et al.
Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol2001;
60: 759–767.
72.
ZhangXZhouKWangR, et al.
Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation. J Biol Chem2007;
282: 10873–10880.
73.
KitaguchiHTomimotoHIharaM, et al.
Chronic cerebral hypoperfusion accelerates amyloid beta deposition in APPSwInd transgenic mice. Brain Res2009;
1294: 202–210.
74.
ZhaoLMaoZWoodySK, et al.
Sex differences in metabolic aging of the brain: insights into female susceptibility to Alzheimer's disease. Neurobiol Aging2016;
42: 69–79.
75.
MathysHDavila-VelderrainJPengZ, et al.
Single-cell transcriptomic analysis of Alzheimer’s disease. Nature2019;
570: 332–337.
76.
BärK-JBoettgerMKSeidlerN, et al.
Influence of galantamine on vasomotor reactivity in Alzheimer’s disease and vascular dementia due to cerebral microangiopathy. Stroke2007;
38: 3186–3192.
77.
DuttaSSenguptaP.Men and mice: relating their ages. Life Sci2016;
152: 244–248.
78.
BennettRERobbinsABHuM, et al.
Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer's disease. Proc Natl Acad Sci U S A2018;
115: e1289–e1298.
79.
SasaguriHNilssonPHashimotoS, et al.
APP mouse models for Alzheimer's disease preclinical studies. EMBO J2017;
36: 2473–2487.
80.
MaiaLFKaeserSAReichwaldJ, et al.
Changes in amyloid-β; and tau in the cerebrospinal fluid of transgenic mice overexpressing amyloid precursor protein. Sci Transl Med2013;
5: 194re192–194re192.
81.
NiwaKCarlsonGAIadecolaC.Exogenous a beta1-40 reproduces cerebrovascular alterations resulting from amyloid precursor protein overexpression in mice. J Cereb Blood Flow Metab2000;
20: 1659–1668.
82.
XiaDLianoglouSSandmannT, et al.
Novel app knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia. Mol Neurodegener2022;
17: 41.
83.
ParkKChenWVolkowND, et al.
Hemodynamic and neuronal responses to cocaine differ in awake versus anesthetized animals: optical brain imaging study. NeuroImage2019;
188: 188–197.
84.
DuCParkKHuaY, et al.
Astrocytes modulate cerebral blood flow and neuronal response to cocaine in prefrontal cortex. Mol Psychiatry2024;
29: 820–834.
85.
PanYParkKRenJ, et al.
Dynamic 3D imaging of cerebral blood flow in awake mice using self-supervised-learning-enhanced optical coherence doppler tomography. Commun Biol2023;
6: 298.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
